These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1335635)

  • 1. Prevention of viral hepatitis A: past, present and future.
    Deinhardt F
    Vaccine; 1992; 10 Suppl 1():S10-4. PubMed ID: 1335635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible approaches to develop vaccines against hepatitis A.
    D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S48-52. PubMed ID: 1335659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination against hepatitis A].
    Giusti G; Russo M
    Recenti Prog Med; 1992 Jun; 83(6):313-20. PubMed ID: 1323136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of hepatitis A by inactivated vaccines: unanswered questions and unresolved issues.
    Purcell RH
    J Hepatol; 1993; 18 Suppl 2():S61-4. PubMed ID: 8182277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts.
    Kendall BJ; Cooksley WG
    Drugs; 1991 Jun; 41(6):883-8. PubMed ID: 1715265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination.
    Fujiyama S; Odoh K; Kuramoto I; Mizuno K; Tsurusaki R; Sato T
    J Hepatol; 1994 Oct; 21(4):641-5. PubMed ID: 7814811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the control of hepatitis A by vaccination.
    Kane MA
    Vaccine; 1992; 10 Suppl 1():S93-6. PubMed ID: 1335670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulin.
    Lemon SM; Murphy PC; Provost PJ; Chalikonda I; Davide JP; Schofield TL; Nalin DR; Lewis JA
    J Infect Dis; 1997 Jul; 176(1):9-19. PubMed ID: 9207344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection.
    Robertson BH; D'Hondt EH; Spelbring J; Tian H; Krawczynski K; Margolis HS
    J Med Virol; 1994 Jul; 43(3):249-51. PubMed ID: 7931186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis virus vaccines: present status.
    Krugman S
    Yale J Biol Med; 1982; 55(3-4):375-81. PubMed ID: 6295013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccine.
    André FE
    J Infect Dis; 1995 Mar; 171 Suppl 1():S33-9. PubMed ID: 7876646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Viral hepatitis and immunoprophylaxis].
    Deinhardt F; Jilg W
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):134-45. PubMed ID: 2986380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine.
    Lemon SM
    J Hepatol; 1993; 18 Suppl 2():S15-9. PubMed ID: 8182266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy.
    Margolis HS; Shapiro CN
    Vaccine; 1992; 10 Suppl 1():S85-7. PubMed ID: 1335667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of hepatitis A prevention in travellers.
    Tormans G; Van Damme P; Van Doorslaer E
    Vaccine; 1992; 10 Suppl 1():S88-92. PubMed ID: 1335668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
    Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W
    Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.